University of Southern California, Norris Comprehensive Cancer Center

Los Angeles, California 90033

Use our guide to learn which trials are right for you!

We've found
9 trials
at this facility
Oncology Clinical Trial
CBT-101 Study for Advanced Solid Tumors and c-Met Dysregulation
Status: Enrolling, Phase I
Updated: 12/20/2017
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Urinary Bladder Cancer Clinical Trial
Safety and Tolerability of GemRIS 225 mg in Subjects With Muscle-Invasive Bladder Cancer
Status: Enrolling, Phase I
Updated: 3/6/2018
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Head and Neck Neoplasms Clinical Trial
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hepatocellular Cancer Clinical Trial
A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients
Status: Enrolling, Phase I
Updated: 4/18/2018
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Esophageal Squamous Cell Carcinoma (ESCC) Clinical Trial
A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Patients With Advanced Esophageal Squamous Cell Carcinoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials